When the balance between the production of free radicals and antioxidant defenses occurs, it is referred to as oxidative stress. It is an underlying cause for multiple diseases and an early detector of the potential for many conditions from heart failure to diabetes.
Carmel Diagnostics is excited to be the first company in the world to create a benchtop system that measures oxidative stress in body fluids at the point of care and within minutes. While the potential applications for our ThermoChemiLuminescence (TCL) technology is diverse, we are focusing our efforts toward helping women conceive.
Our technology and our potential contribution to reproductive success have been recognized with significant backing from the EU and from Merck Serono.
Grant recipient from the EU
The company was awarded the prestigious €2.7M grant by Horizon 2020 SME Instrument program of the EU, a formidable achievement that is bestowed on a fraction of applicants.